Masahiro Nishibori Selected Research

glycolaldehyde

11/2021	Involvement of multiple scavenger receptors in advanced glycation end product-induced vessel tube formation in endothelial cells.
1/2021	Advanced glycation end-products reduce lipopolysaccharide uptake by macrophages.
1/2020	A comparative study of sulphated polysaccharide effects on advanced glycation end-product uptake and scavenger receptor class A level in macrophages.
12/2018	Effects of scavenger receptors-1 class A stimulation on macrophage morphology and highly modified advanced glycation end product-protein phagocytosis.
11/2009	Prostaglandin E2 inhibits advanced glycation end product-induced adhesion molecule expression, cytokine production, and lymphocyte proliferation in human peripheral blood mononuclear cells.
9/2009	Histamine inhibits advanced glycation end products-induced adhesion molecule expression on human monocytes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Masahiro Nishibori Research Topics

Disease

29	Inflammation (Inflammations) 10/2022 - 09/2002
19	Sepsis (Septicemia) 04/2022 - 02/2003
16	Neoplasms (Cancer) 03/2022 - 01/2005
10	Pain (Aches) 01/2022 - 01/2016
9	Neuralgia (Stump Neuralgia) 01/2022 - 01/2013
9	Infections 12/2021 - 08/2005
9	Brain Injuries (Brain Injury) 01/2021 - 09/2012
8	Peripheral Nervous System Diseases (PNS Diseases) 03/2022 - 01/2016
8	Ischemia 10/2021 - 08/2006
8	Stroke (Strokes) 01/2021 - 06/2012
7	Reperfusion Injury 10/2021 - 08/2006
7	Hyperalgesia 06/2020 - 01/2016
7	Traumatic Brain Injuries (Traumatic Brain Injury) 05/2019 - 09/2012
6	Hypersensitivity (Allergy) 01/2022 - 06/2007
6	Brain Edema (Cerebral Edema) 02/2019 - 05/2011
6	Neoplasm Metastasis (Metastasis) 01/2019 - 01/2016
5	Diabetes Complications 01/2021 - 03/2010
5	Pneumonia (Pneumonitis) 01/2019 - 06/2015
4	Neuroinflammatory Diseases 01/2022 - 01/2016
4	Melanoma (Melanoma, Malignant) 01/2019 - 01/2016
4	Infarction (Infarctions) 06/2012 - 12/2007
4	Brain Infarction 05/2011 - 12/2007
3	Human Influenza (Influenza) 12/2021 - 01/2018
3	Wounds and Injuries (Trauma) 07/2021 - 04/2019
3	Brain Ischemia (Cerebral Ischemia) 01/2021 - 05/2011
3	Encephalitis (Encephalitis, Rasmussen) 12/2020 - 08/2017
3	Epilepsy (Aura) 12/2020 - 08/2017
3	Thromboinflammation 09/2020 - 07/2016
3	Atherosclerosis 12/2018 - 02/2011
3	Edema (Dropsy) 10/2018 - 04/2016
3	Hepatitis 02/2008 - 09/2004
2	Cognitive Dysfunction 01/2022 - 02/2019
2	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 12/2021 - 10/2018
2	Spinal Cord Injuries (Spinal Cord Injury) 11/2021 - 01/2018
2	Lung Injury 10/2021 - 04/2016
2	Chronic Pain 04/2021 - 01/2013
2	Bacterial Infections (Bacterial Infection) 01/2021 - 01/2018
2	Systemic Inflammatory Response Syndrome (Sepsis Syndrome) 01/2021 - 01/2018
2	Central Nervous System Diseases (CNS Diseases) 12/2020 - 05/2019
2	Hemorrhage 12/2020 - 10/2017
2	Periodontitis 01/2020 - 01/2018
2	Status Epilepticus (Complex Partial Status Epilepticus) 01/2020 - 01/2017
2	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2020 - 05/2011
2	Alzheimer Disease (Alzheimer's Disease) 05/2019 - 10/2005

Drug/Important Bio-Agent (IBA)

67	HMGB1 Protein (HMG1)IBA 04/2022 - 12/2007
20	Monoclonal AntibodiesIBA 11/2021 - 12/2007
16	Proteins (Proteins, Gene)FDA Link 12/2021 - 02/2011
15	histidine-rich proteinsIBA 04/2022 - 11/2009
13	CytokinesIBA 10/2021 - 07/2005
12	LipopolysaccharidesIBA 04/2022 - 02/2003
8	Advanced Glycation End ProductsIBA 11/2021 - 03/2010
7	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2014
7	Neutralizing AntibodiesIBA 01/2021 - 02/2011
7	Histamine (Histamine Dihydrochloride)FDA Link 08/2015 - 09/2002
7	Interleukin-18 (Interleukin 18)IBA 08/2006 - 09/2002
6	LigandsIBA 12/2021 - 08/2006
6	glycolaldehydeIBA 11/2021 - 09/2009
6	Receptor for Advanced Glycation End ProductsIBA 12/2020 - 01/2016
6	Pharmaceutical PreparationsIBA 12/2020 - 10/2005
5	Paclitaxel (Taxol)FDA LinkGeneric 01/2022 - 01/2016
5	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2021 - 10/2006
5	Nuclear Proteins (Protein, Nuclear)IBA 10/2021 - 01/2016
5	Therapeutic UsesIBA 06/2020 - 01/2009
5	ThrombomodulinIBA 06/2020 - 01/2016
5	GlyceraldehydeIBA 01/2020 - 09/2009
5	Toll-Like Receptor 4IBA 01/2019 - 10/2006
4	Minocycline (Cyclops)FDA LinkGeneric 01/2022 - 12/2017
4	Blood Proteins (Serum Proteins)IBA 12/2021 - 07/2016
3	Adenosine Triphosphate (ATP)IBA 01/2022 - 01/2020
3	Clodronic Acid (Clodronate)IBA 01/2022 - 12/2017
3	EndotoxinsIBA 01/2021 - 09/2004
3	Glycoproteins (Glycoprotein)IBA 01/2021 - 12/2018
3	LipidsIBA 01/2021 - 08/2006
3	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 12/2020 - 01/2016
3	Interleukin-6 (Interleukin 6)IBA 01/2020 - 01/2016
3	InterleukinsIBA 01/2020 - 11/2005
3	CD146 AntigenIBA 01/2019 - 04/2018
3	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 04/2006 - 05/2003
2	AntibodiesIBA 10/2022 - 06/2012
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 03/2022 - 10/2019
2	Glycyrrhizic Acid (Glycyrrhizin)IBA 01/2022 - 10/2014
2	ChemokinesIBA 10/2021 - 01/2018
2	salicylhydroxamic acid (SHAM)IBA 10/2021 - 01/2016
2	Carrier Proteins (Binding Protein)IBA 10/2021 - 02/2011
2	Messenger RNA (mRNA)IBA 07/2021 - 01/2018
2	Peroxidase (Myeloperoxidase)IBA 07/2021 - 01/2018
2	Nucleic AcidsIBA 01/2021 - 12/2018
2	Glutamic Acid (Glutamate)FDA Link 01/2021 - 01/2019
2	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2021 - 01/2019
2	Acetylcysteine (Siran)FDA LinkGeneric 01/2020 - 10/2018
2	MAP Kinase Kinase Kinases (MAP Kinase Kinase Kinase)IBA 08/2019 - 01/2019

Therapy/Procedure

19	Therapeutics 10/2022 - 05/2011
10	Ligation 01/2022 - 03/2010
6	Drug Therapy (Chemotherapy) 03/2022 - 01/2016
3	Tooth Extraction (Tooth Extractions) 07/2021 - 01/2018
3	Intraperitoneal Injections 01/2021 - 11/2011
3	Transplantation 01/2018 - 04/2006
3	Intravenous Injections 01/2013 - 12/2007
2	Injections 01/2022 - 12/2017
2	Intravenous Administration 10/2021 - 01/2016